Clinical Effects and Safety of 3% Diquafosol After Cataract Surgery

NCT02608489 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

86

Enrollment

OTHER

Sponsor class

Conditions

Dry Eye Syndromes

Interventions

DRUG: Diquafosol (Diquas)
DRUG: Sodium Hyaluronate (Hyalein)

Sponsor

Soonchunhyang University Hospital